A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma
Open accessThe DOI matches its Crossref record.
Abstract
Clinical outcome in ovarian carcinoma is predicted by progesterone receptor status, indicating an endocrine aspect to this disease. Peripheral leucocyte genomic DNAs were obtained from 41 patients with primary ovarian carcinoma and 83 controls from Ireland, as well as from 26 primary ovarian carcinoma patients and 101 controls in Germany. Southern analysis using a human progesterone receptor (hPR) cDNA probe identified a germline TaqI restriction fragment length polymorphism (RFLP) defined by two alleles: T1, represented by a 2.7 kb fragment; and T2, represented by a 1.9 kb fragment and characterised by an additional TaqI restriction site with respect to T1. An over-representation of T2 in ovarian cancer patients compared with controls in the pooled Irish/German population (P < 0.025) was observed. A difference (P < 0.02) in the distribution of the RFLP genotypes between Irish and German control populations was also observed. The allele distributions could not be shown to differ significantly from Hardy-Weinberg distribution in any subgroup. Using hPR cDNA region-specific probes, the extra TaqI restriction site was mapped to intron G of the hPR gene.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Risch, H. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1774 · Cited by 771
Estrogen, Progesterone and Epithelial Ovarian Cancer
Ho, S.-M. (2003) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-1-73 · Cited by 254
PROGINS receptor gene polymorphism is associated with endometriosis
Wieser, F., Schneeberger, C., Tong, D., Tempfer, C., Huber, J. C., & Wenzl, R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02984-3 · Cited by 120
Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS?
Lattuada, D., Somigliana, E., Viganò, P., Candiani, M., Pardi, G., & Di Blasio, A. M. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02076.x · Cited by 64
de Carvalho, C. V., Nogueira-de-Souza, N. C., Massad Costa, A. M., Baracat, E. C., Girão, M. J. B. C., D'amora, P., Schor, E., & Da Silva, I. D. C. G. (2007) · Gynecological Endocrinology · doi:10.1080/09513590601024707 · Cited by 44
Metadata
- Authors
- McKenna, N., Kieback, D., Carney, D., Fanning, M., McLinden, J., & Headon, D.
- Venue
- British Journal of Cancer
- Published
- 1995-03
- Volume
- 71
- Issue
- 3
- Pages
- 451-455
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2074966947
- Cited by
- 76
- References
- 0
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma. https://app.cochat.ai/papers/10.1038/bjc.1995.92
- The paper
- McKenna, N., Kieback, D., Carney, D., Fanning, M., McLinden, J., & Headon, D. (1995). A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma. British Journal of Cancer. https://doi.org/10.1038/bjc.1995.92
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.